Related Experiment Video

Updated: Mar 3, 2026

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

15.9K

Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin

Yiwen Jiang, Voichita Dana Marinescu, Yuan Xie

    Cell Reports
    |May 4, 2017
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
    09:36

    Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

    Published on: August 29, 2018

    10.8K
    Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
    10:28

    Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

    Published on: January 10, 2018

    8.8K

    Related Experiment Videos

    Last Updated: Mar 3, 2026

    Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
    12:25

    Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

    Published on: January 7, 2014

    15.9K
    Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
    09:36

    Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

    Published on: August 29, 2018

    10.8K
    Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
    10:28

    Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

    Published on: January 10, 2018

    8.8K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.8K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    High-content morphological profiling by Cell Painting in 3D spheroids.

    Nature communications·2026

    Decompressive craniectomy for severe central nervous system infection: a 15-year Swedish multicentre case-series.

    British journal of neurosurgery·2026

    Long-term outcomes following primary resection of intraosseous meningiomas with concurrent cranioplasty: a population-based Swedish multicentre study.

    Acta neurochirurgica·2026

    Cancer-Intrinsic Protein Neddylation Modulates the Intratumoral Immune Landscape to Constrain Immune Checkpoint Blockade Therapy.

    Cancer immunology research·2026

    Brain banking for research: can we achieve efficient banking?

    Frontiers in neurology·2026

    Incidence of altered proteins in the aging brain: Implications for biological diagnostic markers.

    Journal of Alzheimer's disease : JAD·2026

    Cryo-EM and biochemical characterization of a BRAF/CRAF heterodimer shows that the NtA motif negative charge is dispensable for RAF activation.

    Cell reports·2026

    Infection history and TCR sequence features shape the breadth of TCR cross-reactivity.

    Cell reports·2026

    Embryonic reprogramming drives anaplastic transformation in thyroid carcinoma.

    Cell reports·2026

    TIA1 is required for microglial activation in tauopathy.

    Cell reports·2026

    Hexokinase-2 moonlights as a suppressor of STING-mediated innate immunity.

    Cell reports·2026

    AREG mediates transient hepatocellular carcinoma resistance to receptor tyrosine kinase inhibitors.

    Cell reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us